Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma. Newsam AD, Coughlin CA, Trabolsi A, Schatz JH, et al. Leuk Lymphoma 2023 Nov 7:1-8. doi: 10.1080/10428194.2023.2258244.

Read + Share

Amedeo Smart

Independent Medical Education

Newsam AD, Coughlin CA, Trabolsi A, Schatz JH, et al. Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma. Leuk Lymphoma 2023 Nov 7:1-8. doi: 10.1080/10428194.2023.2258244.
PMID: 37933565